Client updates / Cannabis

2 January 2019 / Hagit Ross

The Israel Securities Authority published an announcement to investors with various emphases about public companies operating in the medical cannabis market. Its announcement calls investors’ attention to several parameters they should consider when deciding whether to invest in securities of public companies operating, or expecting to begin operating, in the medical cannabis market.

See full article >

Categories: Capital Markets | Healthcare Regulatory | Public companies

Amendment to Hazardous Drugs Ordinance Promotes Regulation in Cannabis Market

1 January 2019 / Anat Even-Chen, Ilan Blumenfeld

On December 25, 2018, the Israeli parliament approved the second and third readings of an amendment to the Hazardous Drugs Ordinance (Delegation of Supervisory and Enforcement Authorities Relating to Cannabis for Medicinal and Research Purposes).

See full article >

Categories: Healthcare Regulatory | Regulation

Search by Practice

Client updates / Cannabis